Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older

Sanofi Pasteur, a Sanofi Company · 2011
ClinicalTrials.gov · Datasets · License: Public Domain · 2011
Open Source ↗
diphtheriapertussispoliomyelitis
diphtheria, tetanus, poliomyelitis, pertussis, pertussis (acellular), biological/vaccine, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 854080
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.